Reata Pharmaceuticals Inc... (RETA)
Reata Pharmaceuticals Max Pain By Strike
RETA trades at $172.36, 11.2% above the near-term max pain of $155 expiring Jan 16, 2026 (153 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is stable across expirations ($155-$155), indicating stable market expectations. High dispersion in max pain levels suggests competing forces and potential volatility.
Reata Pharmaceuticals Max Pain By Expiry
Max pain for RETA shows stable levels around 155.00, reflecting balanced market expectations. The 0% spread suggests strong consensus on fair value. Most levels below 172.36 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Jan 16, 2026 | 155 | -17.36 (-10.07%) |